Doctor profile · Federal record
Dr. Daniel Ahn, D.O.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Scottsdale, AZ
- NPI 1669633897
- Accepts Medicare
- MIPS 78.6 / 100 · 2023
- 18 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
13400 E Shea Blvd
Scottsdale, AZ 85259
(480) 301-8000
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- September 8, 2020
- Year of graduation
- 2008 — 18 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Arizona #006924 · Texas #N9156
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1669633897. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
55,319
Distinct HCPCS
10
Medicare allowed
$1,484,102
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,160 | 52 | $47 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,404 | 33 | $54 | |
J9299 |
Injection, nivolumab, 1 mg | 6,880 | 13 | $30 | |
J1453 |
Injection, fosaprepitant, 1 mg | 5,850 | 35 | $0 | |
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 4,800 | 12 | $0 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 4,340 | 12 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 2,400 | 16 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 1,980 | 18 | $23 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,630 | 20 | $30 | |
Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 1,245 | 17 | $31 |
In context: peer comparison
Among 28 peers in Scottsdale Hematology & Oncology Physician, average services per provider: 963. This provider delivers 57× the peer median.Open Payments
Industry payments received
All-time total
$20,017
Transactions
24
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | 8 | $11,469.97 | |
| Incyte Corporation | 11 | $8,165.59 | |
| Exelixis INC. | 1 | $174.00 | |
| Pfizer INC. | 1 | $82.27 | |
| Genentech USA, INC. | 2 | $75.11 | |
| Johnson & Johnson Surgical Vision, INC. | 1 | $49.78 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
97
Patients
59
Total drug cost
$1,032
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prochlorperazine Maleate | Generic | 45 | 33 | $513 |
| Ondansetron Hcl | Generic | 41 | 26 | $337 |
| Ondansetron Odt (Ondansetron) | Brand | 11 | 0 | $182 |
Hospital affiliations
Frequently asked questions
What is Dr. Daniel Ahn's medical specialty?
Dr. Daniel Ahn practices Hematology & Oncology Physician in Scottsdale, AZ.
Where does Dr. Daniel Ahn practice?
Dr. Daniel Ahn practices at 13400 E Shea Blvd, Scottsdale, AZ 85259. Office phone: 4803018000.
What is Dr. Daniel Ahn's NPI?
Dr. Daniel Ahn's National Provider Identifier (NPI) is 1669633897, issued by NPPES.
Does Dr. Daniel Ahn accept Medicare assignment?
Yes. Dr. Daniel Ahn accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Ahn commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, nivolumab, 1 mg (HCPCS J9299). Source: CMS Medicare Physician & Other Practitioners file.